AbCellera Biologics Inc. (ABCL)
2.23
-0.08 (-3.46%)
At close: Mar 31, 2025, 3:59 PM
2.25
0.94%
After-hours: Mar 31, 2025, 06:32 PM EDT
AbCellera Biologics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Cash & Equivalents | 156.32M | 133.32M | 386.54M | 476.14M | 594.12M | 7.55M | 10.44M |
| Short-Term Investments | 469.29M | 627.26M | 499.95M | 246.84M | n/a | n/a | n/a |
| Long-Term Investments | 82.3M | 65.94M | 72.52M | 50.31M | 19.25M | n/a | n/a |
| Other Long-Term Assets | 96.54M | 94.24M | 41.03M | 23.23M | 2.49M | 2.37M | n/a |
| Receivables | 33.62M | 64.38M | 38.59M | 160.58M | 213.24M | 2.12M | 1.4M |
| Inventory | n/a | 1.11M | 1.53M | 1.67M | 1.41M | 163K | 1.00 |
| Other Current Assets | 92.14M | 45.91M | 98.88M | 44.58M | 4.56M | 2.8M | 550.34K |
| Total Current Assets | 751.37M | 871.99M | 1.03B | 929.8M | 813.33M | 12.64M | 15.16M |
| Property-Plant & Equipment | 340.43M | 287.7M | 217.25M | 111.62M | 17.92M | 8.48M | 6.33M |
| Goodwill & Intangibles | 89.92M | 168.23M | 179.31M | 196.2M | 146.65M | n/a | n/a |
| Total Long-Term Assets | 609.18M | 616.11M | 515.42M | 388.77M | 192.21M | 10.85M | 6.33M |
| Total Assets | 1.36B | 1.49B | 1.54B | 1.32B | 1.01B | 23.49M | 21.49M |
| Account Payables | 34.35M | 25.51M | 14.83M | 14.92M | 7.32M | 1.64M | 1.52M |
| Deferred Revenue | 13.52M | 18.96M | 21.61M | 7.54M | 6.59M | 3.24M | 2.33M |
| Short-Term Debt | n/a | 6.16M | 5.58M | 3.65M | 865K | 2.89M | 2.53M |
| Other Current Liabilities | 28.74M | 68.39M | 76.3M | 58.88M | 52.56M | 3.36M | 50.12K |
| Total Current Liabilities | 76.61M | 119.01M | 118.32M | 120.68M | 103.49M | 7.89M | 6.43M |
| Long-Term Debt | 60.74M | 71.22M | 76.67M | 36.41M | 5.91M | 4M | 911.22K |
| Other Long-Term Liabilities | 80.45M | 10.82M | 19.14M | 37.62M | 13.57M | -138 | 277.13K |
| Total Long-Term Liabilities | 151.25M | 216.76M | 189.31M | 172.16M | 71.54M | 5.34M | 3.45M |
| Total Liabilities | 304.47M | 335.78M | 307.63M | 292.84M | 175.03M | 13.24M | 9.88M |
| Total Debt | 60.74M | 77.38M | 82.26M | 36.41M | 6.1M | 6.89M | 3.44M |
| Common Stock | 777.17M | 753.2M | 734.37M | 722.43M | 710.39M | 5.12M | 5.07M |
| Retained Earnings | n/a | 279.79M | 426.19M | 267.67M | 114.2M | -4.72M | -2.5M |
| Comprehensive Income | -4.38M | -1.72M | -1.39M | 280K | 0.00 | 0.00 | -1.55M |
| Shareholders Equity | 1.06B | 1.15B | 1.23B | 1.03B | 830.51M | 10.25M | 11.61M |
| Total Investments | 551.59M | 693.2M | 572.47M | 297.15M | 19.25M | n/a | n/a |